|
Jun 17
|
Heng Ren urges Sinovac board to pay $55 cash dividend before July 8 vote
|
|
Jun 17
|
Prime Success Sets the Record Straight Regarding Continued False and Misleading Statements from Sinovac Biotech’s Current Board
|
|
Jun 16
|
SAIF Partners Files Definitive Proxy Materials in Connection with Sinovac Biotech 2025 Special Meeting of Shareholders; Nominates Ten Highly Qualified Director Candidates to the Board
|
|
Jun 16
|
SINOVAC Board of Directors Alerts Shareholders to Advantech/Prime Success’ New Lawsuit, Which Threatens to Prevent Payment of US$55.00 Special Dividend to All Valid Shareholders
|
|
Jun 14
|
Prime Success Responds to Sinovac Biotech’s False and Misleading Claims
|
|
Jun 12
|
SINOVAC’s Board of Directors Issues a Letter to Shareholders Outlining Clear Pathway to Restore Fairness and Deliver Value to All Shareholders
|
|
Jun 11
|
Vivo Capital Issues Letter to Sinovac Biotech Shareholders Addressing the Company’s False and Misleading Claims
|
|
Jun 10
|
Prime Success Sends Letter to Sinovac Biotech Shareholders
|
|
Sep 11
|
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
|
|
Sep 5
|
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
|
|
May 1
|
SINOVAC Reports Unaudited Second Half of 2022 Financial Results and Files 2022 Annual Report on Form 20-F
|